• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

San Francisco City Guide

Are you headed to San Francisco this month? Check out our podcast to find the best places to dine, visit and shop!

 

Subscribe

Return to Dermatology Times Radio

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
Related Content
Innovating Scalp Care: How Research and Education Drive Solutions
January 15th 2025

Innovating Scalp Care: How Research and Education Drive Solutions

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Role of Zinc, Copper, and Vitamin D in Alopecia Areata Explored
January 14th 2025

Role of Zinc, Copper, and Vitamin D in Alopecia Areata Explored

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

QRX003 Shows Promise in Pediatric Patients with Netherton Syndrome, Quoin Announces
January 14th 2025

QRX003 Shows Promise in Pediatric Patients with Netherton Syndrome, Quoin Announces

High-Risk CSCC Trial Validates Cemiplimab's Potential
January 14th 2025

High-Risk CSCC Trial Validates Cemiplimab's Potential

© 2025 MJH Life Sciences

All rights reserved.